Top Markets
#1 MowCat MowCat +49.07%
#2 Velvet Velvet +36.37%
#3 Derive Derive +20.53%
#4 Audiera Audiera +19.69%
#5 Bermuda Shorts Bermuda Shorts +18.78%
#6 Quack AI Quack AI +18.60%
#7 MarsCoin MarsCoin +16.65%
#8 aPriori aPriori +15.97%
#9 Biconomy Biconomy +13.82%
#10 Cross Cross +12.08%
Coin of the day
MowCat MowCat
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Qualigen Therapeutics, Inc. Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc.

QLGN
Rang in aandelen #35381
Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing... Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company offers FastPack, an efficient system designed for swift diagnostic testing. Its therapeutic candidates currently undergoing development include QN-302, an investigational compound targeting pancreatic ductal adenocarcinoma; QN-247, a DNA-coated gold nanoparticle formulated to combat various types of cancer; and RAS-F, a small-molecule inhibitor designed to block RAS oncogene protein-protein interactions, thereby impeding RAS mutations and suppressing tumor growth. The company is also progressing with the STARS blood cleansing system, an innovative DNA/RNA-based device engineered to purify a patient's bloodstream by eliminating tumor-derived substances and viruses. Founded in 1996, Qualigen Therapeutics, Inc. is headquartered in Carlsbad, California.
Aandeelprijs
$2.37
Laatst gesynchroniseerd: 2025-12-15
Marktkapitalisatie
$3.99M
Verandering (1 dag)
-5.58%
Verandering (1 jaar)
24.74%
Land
US
Handel Qualigen Therapeutics, Inc. (QLGN)

Categorie

Healthcare
Aandelsplitsingen voor Qualigen Therapeutics, Inc. (QLGN)
Het aandeel Qualigen Therapeutics, Inc. (symbool: QLGN) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 16, 2026.
Eén aandeel QLGN dat vóór Aug 16, 2026 werd gekocht, staat nu gelijk aan 0 aandelen QLGN.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE